Your session is about to expire
← Back to Search
Prospective Control Group for Spider Veins
N/A
Waitlist Available
Led By Kristen M Kelly, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; average of one year
Awards & highlights
Study Summary
This trial is testing whether using an imaging device to get information about a skin lesion can help guide laser treatment. The study will use different types of lasers, all of which are FDA-cleared for other indications.
Eligible Conditions
- Spider Veins
- Rosacea
- Port-Wine Stain
- Angioma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion; average of one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; average of one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of Change in Photographed Lesion
Other outcome measures
Number of Participants With Scarring, Blistering, Bruising, and Scabbing
Trial Design
2Treatment groups
Experimental Treatment
Group I: Prospective Study GroupExperimental Treatment1 Intervention
For the experimental group, the laser surgeon will be exposed to the OCT measurements and will select laser settings and determine treatment parameters based on the measurements.
Group II: Prospective Control GroupExperimental Treatment1 Intervention
For the control group, the laser surgeon will not be exposed to the OCT measurements and will select laser settings and determine treatment parameters based on standard of care, intuition, and experience.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Optical Coherence Tomography
2016
Completed Phase 2
~1510
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
542 Previous Clinical Trials
1,921,946 Total Patients Enrolled
Kristen M Kelly, MDPrincipal InvestigatorUniversity of California, Irvine
2 Previous Clinical Trials
761 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger